Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance
- PMID: 39277592
- PMCID: PMC11401928
- DOI: 10.1038/s41467-024-52375-6
Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance
Abstract
Recent advances in high-resolution mapping of spatial interactions among regulatory elements support the existence of complex topological assemblies of enhancers and promoters known as enhancer-promoter hubs or cliques. Yet, organization principles of these multi-interacting enhancer-promoter hubs and their potential role in regulating gene expression in cancer remain unclear. Here, we systematically identify enhancer-promoter hubs in breast cancer, lymphoma, and leukemia. We find that highly interacting enhancer-promoter hubs form at key oncogenes and lineage-associated transcription factors potentially promoting oncogenesis of these diverse cancer types. Genomic and optical mapping of interactions among enhancer and promoter elements further show that topological alterations in hubs coincide with transcriptional changes underlying acquired resistance to targeted therapy in T cell leukemia and B cell lymphoma. Together, our findings suggest that enhancer-promoter hubs are dynamic and heterogeneous topological assemblies with the potential to control gene expression circuits promoting oncogenesis and drug resistance.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures







Update of
-
Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance.bioRxiv [Preprint]. 2024 Jul 2:2024.07.02.601745. doi: 10.1101/2024.07.02.601745. bioRxiv. 2024. Update in: Nat Commun. 2024 Sep 14;15(1):8070. doi: 10.1038/s41467-024-52375-6. PMID: 39005446 Free PMC article. Updated. Preprint.
Similar articles
-
Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance.bioRxiv [Preprint]. 2024 Jul 2:2024.07.02.601745. doi: 10.1101/2024.07.02.601745. bioRxiv. 2024. Update in: Nat Commun. 2024 Sep 14;15(1):8070. doi: 10.1038/s41467-024-52375-6. PMID: 39005446 Free PMC article. Updated. Preprint.
-
Oncogenic transcription factors instruct promoter-enhancer hubs in individual triple negative breast cancer cells.Sci Adv. 2024 Aug 9;10(32):eadl4043. doi: 10.1126/sciadv.adl4043. Epub 2024 Aug 7. Sci Adv. 2024. PMID: 39110799 Free PMC article.
-
Spatial promoter-enhancer hubs in cancer: organization, regulation, and function.Trends Cancer. 2023 Dec;9(12):1069-1084. doi: 10.1016/j.trecan.2023.07.017. Epub 2023 Aug 19. Trends Cancer. 2023. PMID: 37599153 Free PMC article. Review.
-
Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.Epigenetics Chromatin. 2016 Nov 9;9:50. doi: 10.1186/s13072-016-0102-4. eCollection 2016. Epigenetics Chromatin. 2016. PMID: 27833659 Free PMC article.
-
Dynamic modulation of enhancer-promoter and promoter-promoter connectivity in gene regulation.Bioessays. 2024 Sep;46(9):e2400101. doi: 10.1002/bies.202400101. Epub 2024 Jun 25. Bioessays. 2024. PMID: 38922969 Review.
Cited by
-
CREPT is required for the metastasis of triple-negative breast cancer through a co-operational-chromatin loop-based gene regulation.Mol Cancer. 2025 Jun 10;24(1):170. doi: 10.1186/s12943-025-02361-3. Mol Cancer. 2025. PMID: 40495214 Free PMC article.
-
MultiVis.js: a software tool for the visualization of multiway chromatin interactions and SPRITE data.BMC Bioinformatics. 2025 Jun 2;26(1):144. doi: 10.1186/s12859-025-06176-3. BMC Bioinformatics. 2025. PMID: 40457193 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases